−Removed: our knowledge, neither the Company nor any of our officers or directors is a party to any material legal proceeding or litigation and
−Removed: such persons know of no material legal proceeding or contemplated or threatened litigation, other than as described below.
−Removed: no judgments against us or our officers or directors.
−Removed: None of our officers or directors has been convicted of a felony or misdemeanor
−Removed: relating to securities or performance in corporate office.
−Removed: SAFETY DISCLOSURES
+Added: LEGAL PROCEEDINGS
+Added: To our knowledge, other than described below, neither
+Added: the Company nor any of our officers or directors is a party to any material legal proceeding or litigation and such persons know of no
+Added: material legal proceeding or contemplated or threatened litigation, other than as described below.
+Added: There are no judgments against us or
+Added: our officers or directors.
+Added: None of our officers or directors has been convicted of a felony or misdemeanor relating to securities or performance
+Added: in corporate office.
+Added: On January 19, 2024, a purported shareholder
+Added: class action complaint, captioned Eric Olmstead v.
+Added: 3:24-cv-00035, was filed in the U.S.
+Added: Court for the District of Nevada, naming the Company and certain of its officers as defendants.
+Added: On February 22, 2024, a second,
+Added: related putative securities class action was filed in the same court asserting similar claims against the same defendants, captioned Way
+Added: 2:24-cv-00361.
+Added: On April 15, 2024, the court consolidated these two actions under the caption In re
+Added: Securities Litigation , No.
+Added: 3:24-cv-00035, appointed the lead plaintiff, and approved selection of the lead counsel.
+Added: On June 21, 2024, the lead plaintiff filed an amended complaint, alleging that the defendants made material misrepresentations
+Added: and/or omissions of material fact relating to the Company’s business, operations, compliance, and prospects, including
+Added: information related to the NM101 Phase 3 study and trial of bezisterim (NE3107) in mild to moderate probable AD, in
+Added: violation of Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 promulgated thereunder.
+Added: The class action
+Added: is on behalf of purchasers of the Company’s securities during the period from December 7, 2022 through November 28, 2023 and
+Added: seeks unspecified monetary damages on behalf of the putative class and an award of costs and expenses, including attorney’s
+Added: The defendants filed a motion to dismiss the amended complaint on August 21, 2024.
+Added: The defendants believe that the
+Added: claims are without merit and intend to defend vigorously against them, but there can be no assurances as to the outcome.
+Added: MINE SAFETY DISCLOSURES
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.